Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Jaguar Health (JAGX) Convertible Debt (2017 - 2018)

Jaguar Health (JAGX) has disclosed Convertible Debt for 2 consecutive years, with $10.7 million as the latest value for Q3 2018.

Quarterly Convertible Debt fell 4.48% to $10.7 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $10.7 million through Sep 2018, down 4.48% year-over-year, with the annual reading at $11.0 million for FY2017, N/A changed from the prior year.
Convertible Debt for Q3 2018 was $10.7 million at Jaguar Health, down from $11.0 million in the prior quarter.
The five-year high for Convertible Debt was $11.2 million in Q3 2017, with the low at $10.7 million in Q3 2018.